Terrence A Duffy
CIK 1212809 · View on SEC EDGAR ↗
Insider
First SEC filing: March 18, 2025 · Latest: March 18, 2025
On this page
Insider at
Insider transactions
0 buys (P)
2 sells (S)
Net:
$-10,447,865
+ 77 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
77 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | CME | S | 9,004 | $299.58 | $2,697,418 | 55,630 Direct | -13.93% | Disposed | -9.9% (price as of 2026-08-19) |
| May 15, 2026 | CME | S | 25,996 | $298.14 | $7,750,447 | 64,634 Direct | -28.68% | Disposed | -9.5% (price as of 2026-08-19) |
| March 11, 2025 | CME | S | 30,000 | $259.18 | $7,775,400 | 53,205 Direct | -36.06% | Disposed | 4.1% (price as of 2026-08-19) |
| April 29, 2024 | CME | S | 25,216 | $211.44 | $5,331,671 | 67,455 Direct | -27.21% | Disposed | 27.6% (price as of 2026-08-19) |
| April 29, 2024 | CME | S | 10,708 | $210.20 | $2,250,822 | 92,671 Direct | -10.36% | Disposed | 28.4% (price as of 2026-08-19) |
| April 29, 2024 | CME | S | 4,076 | $209.52 | $854,004 | 103,379 Direct | -3.79% | Disposed | 28.8% (price as of 2026-08-19) |
| Aug. 18, 2023 | CME | S | 30,000 | $203.95 | $6,118,500 | 65,545 Direct | -31.40% | Disposed | 32.3% (price as of 2026-08-19) |
| Nov. 5, 2021 | CME | P | 400 | $222.02 | $88,808 | 81,308 Direct | +0.49% | Acquired | 21.5% (price as of 2026-08-19) |
| Nov. 4, 2021 | CME | P | 600 | $220.26 | $132,156 | 80,908 Direct | +0.75% | Acquired | 22.5% (price as of 2026-08-19) |
| Nov. 4, 2021 | CME | P | 100 | $220.20 | $22,020 | 80,308 Direct | +0.12% | Acquired | 22.6% (price as of 2026-08-19) |
| Nov. 4, 2021 | CME | P | 200 | $220.21 | $44,042 | 80,208 Direct | +0.25% | Acquired | 22.5% (price as of 2026-08-19) |
| Nov. 4, 2021 | CME | P | 300 | $220.21 | $66,063 | 80,008 Direct | +0.38% | Acquired | 22.5% (price as of 2026-08-19) |
| Nov. 4, 2021 | CME | P | 100 | $220.21 | $22,021 | 79,708 Direct | +0.13% | Acquired | 22.5% (price as of 2026-08-19) |
| Nov. 4, 2021 | CME | P | 300 | $220.13 | $66,039 | 79,608 Direct | +0.38% | Acquired | 22.6% (price as of 2026-08-19) |
| May 19, 2021 | CME | S | 29,000 | $210.83 | $6,114,070 | 55,492 Direct | -34.32% | Disposed | 28.0% (price as of 2026-08-19) |
| Dec. 12, 2019 | CME | S | 39,309 | $202.38 | $7,955,355 | 46,684 Direct | -45.71% | Disposed | 33.3% (price as of 2026-08-19) |
| Aug. 1, 2019 | CME | S | 35,000 | $200.15 | $7,005,250 | 79,057 Direct | -30.69% | Disposed | 34.8% (price as of 2026-08-19) |
| Nov. 23, 2018 | CME | S | 10,000 | $188.80 | $1,888,000 | 95,652 Direct | -9.47% | Disposed | 42.9% (price as of 2026-08-19) |
| May 22, 2018 | CME | S | 20,000 | $161.00 | $3,220,000 | 94,686 Direct | -17.44% | Disposed | 67.6% (price as of 2026-08-19) |
| Feb. 6, 2018 | CME | S | 20,000 | $151.66 | $3,033,200 | 99,239 Direct | -16.77% | Disposed | 77.9% (price as of 2026-08-19) |
| Aug. 2, 2017 | CME | S | 21,815 | $123.89 | $2,702,660 | 110,711 Direct | -16.46% | Disposed | 117.8% (price as of 2026-08-19) |
| Dec. 8, 2016 | CME | S | 27,550 | $120.44 | $3,318,122 | 110,364 Direct | -19.98% | Disposed | 124.1% (price as of 2026-08-19) |
| Nov. 25, 2016 | CME | S | 17,375 | $112.58 | $1,956,078 | 110,364 Direct | -13.60% | Disposed | 139.7% (price as of 2026-08-19) |
Showing latest 100 of 212 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 8, 2016 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (27,550) | $110.54 | June 15, 2017 | 27,550 | Disposed |
| Nov. 25, 2016 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (17,375) | $105.90 | Dec. 15, 2016 | 17,375 | Disposed |
| March 9, 2016 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (5,340) | $54.37 | Sept. 15, 2021 | 5,340 | Disposed |
| Feb. 11, 2015 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (30,875) | $83.88 | June 16, 2018 | 30,875 | Disposed |
| Nov. 3, 2014 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (5,340) | $54.37 | Sept. 15, 2021 | 5,340 | Disposed |
| Nov. 3, 2014 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (9,240) | $54.30 | Sept. 15, 2020 | 9,240 | Disposed |
| Nov. 21, 2013 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (7,945) | $56.87 | Sept. 15, 2019 | 7,945 | Disposed |
| Nov. 21, 2013 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (5,340) | $54.37 | Sept. 15, 2021 | 5,340 | Disposed |
| Nov. 21, 2013 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (9,240) | $54.30 | Sept. 15, 2020 | 9,240 | Disposed |
| March 14, 2013 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (15,890) | $56.87 | Sept. 15, 2019 | 15,890 | Disposed |
| March 14, 2013 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (5,340) | $54.37 | Sept. 15, 2021 | 5,340 | Disposed |
| March 14, 2013 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (18,480) | $54.30 | Sept. 15, 2020 | 18,480 | Disposed |
| Sept. 15, 2011 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (4,272) | $271.86 | Sept. 15, 2021 | 4,272 | Acquired |
| Feb. 28, 2011 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (1,589) | $284.34 | Sept. 15, 2019 | 1,589 | Disposed |
| Sept. 15, 2010 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (7,392) | $271.49 | Sept. 15, 2020 | 7,392 | Acquired |
| Sept. 15, 2010 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (7,392) | $271.49 | Sept. 15, 2020 | 7,392 | Acquired |
| Sept. 15, 2010 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (7,392) | $271.49 | Sept. 15, 2020 | 7,392 | Acquired |
| Sept. 15, 2009 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (6,356) | $284.34 | Sept. 15, 2019 | 6,356 | Acquired |
| June 16, 2008 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (6,175) | $419.41 | June 16, 2018 | 6,175 | Acquired |
| June 15, 2007 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (5,510) | $552.70 | June 15, 2017 | 5,510 | Acquired |
| Dec. 15, 2006 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (3,475) | $529.50 | Dec. 15, 2016 | 3,475 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CME
CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $1,500,000 | — | — | — | $3,195,001 | $45,422 | $444,441 | $16,118,467 |
| 2019 | $1,500,000 | — | — | — | $3,208,570 | $50,352 | $569,392 | $11,867,214 |
| 2018 | $1,500,000 | — | — | — | $4,591,913 | $26,445 | $469,126 | $13,416,665 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.